WHO supports the Government of Niger COVID-19 vaccination with the USAID and other donors financial support
Since March 29, 2021, the Government of Niger has started Covid-19 vaccination roll out that was launched in Niamey by the Prime Minister and across the country on 4 May 2021 by the Minister of Public Health, Population and Social Affairs, Dr Illiassou MAINASSARA. This campaign was made possible thanks to the vaccines received from the bilateral cooperation and the Co-vax facility.
However, this vaccination faced many challenges such as the availability of suffi-cient stocks of vaccines and the funding for the operational costs.
To address this situation and in complementarity with the contributions of other partners, the Government of the United States of America donated 302,400 doses of Johnson & Johnson vaccines to Niger and a financial sup-port for the operational costs; the world health organization (WHO) is honored to be the recipient of this funding that has been used to support the Government to reach the goal of vaccinating 30% of Niger total popula-tion by December 2021.
On October 20th 2021, 695,498 people aged 18 year-old and over have received a first dose of (Astrazeneca and Sinopharm), 200 048 people have received the single dose of Johnson and Johnson and 389,119 people are fully vaccinated which represent 1% of the total popu-lation fully vaccinated.
However, this vaccination faced many challenges such as the availability of suffi-cient stocks of vaccines and the funding for the operational costs.
To address this situation and in complementarity with the contributions of other partners, the Government of the United States of America donated 302,400 doses of Johnson & Johnson vaccines to Niger and a financial sup-port for the operational costs; the world health organization (WHO) is honored to be the recipient of this funding that has been used to support the Government to reach the goal of vaccinating 30% of Niger total popula-tion by December 2021.
On October 20th 2021, 695,498 people aged 18 year-old and over have received a first dose of (Astrazeneca and Sinopharm), 200 048 people have received the single dose of Johnson and Johnson and 389,119 people are fully vaccinated which represent 1% of the total popu-lation fully vaccinated.
